 random trial intraven oral etoposid combin cisplatin treatment small cell lung cancer random multi-cent studi patient small cell lung cancer treatment cisplatin IV day IV day IV day IV day day regimen week prior random patient extent diseas perform statu gender total patient parenter treatment regimen patient cisplatin iv/or therapi treatment arm compar patient characterist limit diseas LD patient patient popul oral IV overal complet respons CR partial respons PR rate confid interv CI oral etoposid regimen CI IV etoposid regimen regimen LD patient CR PR time progress surviv compar treatment arm hematolog toxic compar treatment arm patient grade neutropenia thrombocytopenia moder anemia weight loss predomin IV oral regimen